OCULIS
Summary
Oculis is a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients.
Deals Overview
Total Deals2
Valued Deals2
Total Value£235M
Avg. Deal Size£118M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
